Kerry A. Rogers, MD, accents the "chronic" aspect of chronic lymphocytic leukemia (CLL) and how patients are affected by the way specific treatments blend with the circumstances of their lives.
Summing up the advances made over recent decades, Dr Rogers notes how treatment extended over time reveals a range of response, in that patients previously without good options might benefit from more novel therapies, often in the context of clinical trials.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Taking the Long View in the Treatment of CLL - Medscape - May 30, 2023.
Comments